A new drug for pancreatic cancer has shown promising results in a clinical trial, with some reports indicating it can nearly double or almost double the survival time for patients. The treatment, which comes in the form of a daily pill, has been described as a potential game-changer for one of the deadliest cancers. The drug's effectiveness has been characterized as "unprecedented" and "landmark" in some reports, with doctors now exploring its potential uses beyond pancreatic cancer.